PRTN3 and rheumatoid arthritis: Having the tool of ACPA IgG1 Fab profiling at hand, we applied the approach to plasma obtained from eight RA patients with varying ACPA IgG levels and ACPA fine-specificities (Supplementary Table 1, Supplementary Fig. 3).